Pioglitazone Reduces Dementia Risk in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Analysis

Background: The beneficial effect of pioglitazone on dementia requires confirmation. Methods: The database of Taiwan’s National Health Insurance was used to enroll a propensity score-matched-pair cohort of patients who had ever used pioglitazone and patients who had never used pioglitazone from Taiw...

Descripción completa

Detalles Bibliográficos
Autor principal: Tseng, Chin-Hsiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209987/
https://www.ncbi.nlm.nih.gov/pubmed/30262775
http://dx.doi.org/10.3390/jcm7100306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209987/
https://www.ncbi.nlm.nih.gov/pubmed/30262775
http://dx.doi.org/10.3390/jcm7100306

Ejemplares similares